BMH BRÄUTIGAM advises Trioptics on the sale to Jenoptik

BMH BRÄUTIGAM has advised the founders of Trioptics and capiton on the sale of the Trioptics Group based in Wedel to Jenoptik AG, a publicylisted company. The deal was announced by Trioptics, capiton and Jenoptik yesterday. The transaction is subject to approval by the antitrust authorities.

Trioptics was founded in 1991 and has since developed into a world market leader in the field of optical measurement technology with locations in the USA, China, Japan, Taiwan, Singapore, France and Korea. The company's products are used in the manufactoring of smartphones, virtual & augmented reality, medical technology & life science and automotive. Customers include both globally active technology companies and well-known medium-sized companies worldwide. In addition to a broad product portfolio, including automation solutions, Trioptics offers its customers comprehensive services in the field of application development and is strongly involved in their R&D activities. The company is growing dynamically and generated sales of around 80 million euros in 2019. This positive growth trend was able to continue in the first 6 months of the current year despite the COVID 19 crisis. Jenoptik AG is a globally active technology group with the business units Light & Optics, Light & Production and Light & Safety. The focus of the product & service range is photonics. Key markets include semiconductor equipment, medical technology, automotive and mechanical engineering, transportation, aviation, and security and defense technology. Jenoptik employs over 4,100 people worldwide and generated sales of around 855 million euros in the 2019 fiscal year. Background: The lawyers of BMH BRÄUTIGAM have been advising capiton on the acquisition and sale of companies for more than 20 years, most recently on the acquisition of the DEC Group. Team BMH BRÄUTIGAM: Jan-Peter Heyer (Lead), Tina Schmidt, Dr. Manuel Holzmann, Till Wansleben, Dr. Andrea Reichert-Clauß, Dr. Sylko Winkler (all Private Equity ǀ Corporate/M&A)